Invesaro

Stocks ZTO Financial statements

Financial statements

ZTO Express (Cayman) Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ZTO Express (Cayman) Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1,4102,0072,5603,1763,8644,7715,1295,4116,0667,021
Cost of revenue9141,3391,7802,2252,9703,7373,8193,7694,1875,266
Gross profit4966687809518951,0341,3111,6431,8791,755
Selling, general and administrative102120176222255294301342369377
Operating expenses97.191.8150166166170189233266257
Operating income3995766307857298641,1221,4101,6131,498
Interest expense1.872.410.115.4119.927.640.846.335.6
Pre-tax income4065877769717729011,2011,5051,6001,581
Income tax10599.3135155106158237273390272
Net income to minority interests-0.32-0.120.71-0.412.18-8.4-21.80.779.6922.2
Net income2964866378156617469871,2321,2081,299
EBITDA4466627549661,0111,2121,5091,8152,0281,981
EPS, basic0.420.680.851.040.830.911.221.531.501.63
EPS, diluted0.420.680.851.040.830.911.211.491.471.60
Shares, basic (weighted)635717752784796820809808805798
Shares, diluted (weighted)635718753784796820820839838821

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents1,6268346727572,1781,5251,6951,7371,8451,432
Short-term investments8031,9781,5965664468341,0501,2122,234
Receivables28.544.286.89711414611980.6206184
Inventory4.895.266.376.38.13135.883.955.285.81
Other current assets54.6111219282358493456531593730
Total current assets1,8991,9023,0882,8873,4212,9293,5493,7964,1584,857
Property, plant and equipment5869951,3141,7912,8453,9124,1784,5334,6465,067
Lease right-of-use assets13013414111794.777.656.9
Goodwill599652617609650666615597581594
Intangible assets1889.297.896.96.415.594.273.272.347.54
Long-term investments77.493.83211362821911,0621,7141,646747
Other non-current assets6.6247.590.687.982.312011898.8126134
Total assets3,3713,9705,7726,5929,0749,85011,38512,46012,65113,016
Accounts payable91.7137191212251307319360337369
Deferred revenue63.5174172192199246214262
Short-term debt64.838.42205437821,0941,3031,564
Total current liabilities5076377489601,4332,0392,3792,8263,8733,270
Lease liabilities72.57787.37464.251.737.4
Other non-current liabilities9.2313.213.5
Total liabilities5266747871,0751,5492,1733,4873,9704,0643,416
Paid-in capital2,2962,4553,5113,2084,6924,4303,8743,4093,3413,432
Retained earnings5061,0251,6082,4033,2243,5654,2715,1135,3566,137
Treasury stock-141-225-206-395-324-299-72-155-36.4
Other comprehensive income42.4-45.583.297.1-14.6-38-12.6-26.9-40.4-40.2
Shareholders' equity2,8443,2954,9775,5027,5067,6327,8338,4238,5039,493
Minority interests0.820.927.6114.518.545.664.467.483.9108
Total equity2,8453,2954,9845,5167,5257,6787,8988,4908,5869,600
Total liabilities and equity3,3713,9705,7726,5929,0749,85011,38512,46012,65113,016
Shares outstanding785782829808809805799791

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income2954866388156637389651,2331,2181,321
Depreciation and amortization46.886.1124182282349387405414483
Stock-based compensation17.66.2636.345.540.538.92635.943.732.8
Deferred income tax-4.4-4.46-20.2-5.82-41.7-30.135.522.240.1-76.7
Change in receivables-20.4-15.4-45-12.1-12.2-32.9-2.1634.4-12932.8
Change in inventory-2.63-0.04-1.39-0.01-1.41-4.74.21.76-1.44-0.3
Cash from operations3655586419067591,1331,6641,8821,5661,711
Capital expenditures-286-395-483-666-1,109-1,312-1,025-920-714-746
Acquisitions-16.6-16.1-2.81-12.4
Purchases of investments-1,556-1,983-2,020-1,485-2,070-1,387-1,586-1,881-2,160
Cash from investing-492-1,275-1,872-526-544-1,374-2,326-1,726-819-690
Debt issued30.9
Stock issued1,3231,2931,498
Share buybacks-132-112-110-188-598-12.3-142-159-179
Dividends paid-130-183-253-212-192-292-768-537
Cash from financing1,356-1631,024-2851,278-4561,023-108-684-1,511
Exchange rate effect43.5-65.240.1-0.46-101-23.6
Net change in cash1,273-945-167941,392-72041163.165.7-498
Free cash flow79.3163157240-350-179640962852966
Interest paid1.872.410.115.3119.925.735.140.537.3
Income taxes paid93.1134130204152179182235328378

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $19.67 on September 28, 2026.

Profitability

MetricValueHow it is calculated
Gross margin25.0%Gross profit / revenue.
Operating margin21.3%Operating income / revenue.
EBITDA margin28.2%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin22.5%Pre-tax income / revenue.
Net margin18.5%Net income / revenue.
FCF margin13.8%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin24.4%Cash from operations / revenue.
Effective tax rate17.2%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)14.4%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)10.1%Net income / average total assets.
Return on invested capital (ROIC)16.8%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue5.4%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.5%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue10.6%Capital expenditures / revenue.
D&A / revenue6.9%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y15.7%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y11.0%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y12.7%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-6.6%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y10.2%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y14.4%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-7.2%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y10.1%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y15.5%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y-2.3%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y9.5%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y14.4%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y7.5%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y9.6%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y14.5%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y8.8%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y9.8%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y14.0%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y9.3%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y0.9%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y17.7%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y13.3%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y14.7%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y11.6%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y6.6%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y4.8%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y2.9%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y4.6%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y7.5%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-2.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y0.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.6%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.49xCurrent assets / current liabilities.
Quick ratio1.18x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio1.12x(Cash + short-term investments) / current liabilities.
Liabilities / assets26.2%Total liabilities / total assets.
Interest coverage42.1xOperating income / interest expense.
Working capital$1.59BCurrent assets - current liabilities.
Goodwill and intangibles / assets4.6%(Goodwill + intangible assets) / total assets.
Tangible book value$8.89BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.55xRevenue / average total assets.
Fixed asset turnover1.45xRevenue / average property, plant and equipment.
Inventory turnover949xCost of revenue / average inventory.
Days inventory0 days365 x average inventory / cost of revenue.
Receivables turnover36.0xRevenue / average receivables.
Days sales outstanding10 days365 x average receivables / revenue.
Days payables24 days365 x average accounts payable / cost of revenue.
Cash conversion cycle-14 daysDays inventory + days sales outstanding - days payables.
FCF conversion74.4%Free cash flow / net income, when net income is positive.
Capex / operating cash flow43.6%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$1.60Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$1.63Net income per basic share, as reported (split-adjusted).
Revenue per share$8.55Revenue / diluted weighted shares.
FCF per share$1.18Free cash flow / diluted weighted shares.
Operating cash flow per share$2.09Cash from operations / diluted weighted shares.
Book value per share$12.00Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$11.24Tangible book value / shares outstanding.
Cash per share$4.63(Cash + short-term investments) / shares outstanding.
Payout ratio41.4%Dividends paid / net income, when net income is positive.
Dividends / FCF55.6%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF18.5%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$15.14BShare price x shares outstanding.
Enterprise value$11.48BMarket cap + total debt - cash - short-term investments.
P/E11.7xMarket cap / net income. Only when net income is positive.
P/S2.16xMarket cap / revenue.
P/B1.60xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.70xMarket cap / tangible book value, when positive.
P/FCF15.7xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF8.85xMarket cap / cash from operations, when positive.
EV/Sales1.63xEnterprise value / revenue.
EV/EBIT7.66xEnterprise value / operating income, when both are positive.
EV/EBITDA5.79xEnterprise value / EBITDA, when both are positive.
EV/FCF11.9xEnterprise value / free cash flow, when both are positive.
FCF yield6.4%Free cash flow / market cap.
Earnings yield8.6%Net income / market cap (the inverse of P/E).
Dividend yield3.5%Dividends paid over the period / market cap.
Shareholder yield4.7%(Dividends paid + share buybacks) / market cap.
PEG1.19xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was ZTO Express (Cayman) Inc.'s revenue in fiscal 2025?

ZTO Express (Cayman) Inc. reported revenue of $7.02B for fiscal 2025, 15.7% higher than the year before.

Was ZTO Express (Cayman) Inc. profitable in fiscal 2025?

Yes. Net income was $1.30B, a net margin of 18.5%.

How much free cash flow did ZTO Express (Cayman) Inc. generate in fiscal 2025?

Cash from operations of $1.71B minus capital expenditures of $745.6M left free cash flow of $965.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ZTO Express (Cayman) Inc.